Bone Marrow Stromal Antigen 2 Is a Novel Plasma Biomarker and Prognosticator for Colorectal Carcinoma: A Secretome-Based Verification Study
Background. The cancer cell secretome has been recognized as a valuable reservoir for identifying novel serum/plasma biomarkers for different cancers, including colorectal cancer (CRC). This study aimed to verify four CRC cell-secreted proteins (tumor-associated calcium signal transducer 2/trophobla...
Main Authors: | Sum-Fu Chiang, Chih-Yen Kan, Yung-Chin Hsiao, Reiping Tang, Ling-Ling Hsieh, Jy-Ming Chiang, Wen-Sy Tsai, Chien-Yuh Yeh, Pao-Shiu Hsieh, Ying Liang, Jinn-Shiun Chen, Jau-Song Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2015-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2015/874054 |
Similar Items
-
Medications for Hypertension Change the Secretome Profile from Marrow Stromal Cells and Peripheral Blood Monocytes
by: Nikunj Satani, et al.
Published: (2020-01-01) -
The secretome of mesenchymal stromal cells drives functional heterogeneity
by: Andrew Stone, et al.
Published: (2020-10-01) -
Exofucosylation of Adipose Mesenchymal Stromal Cells Alters Their Secretome Profile
by: David García-Bernal, et al.
Published: (2020-11-01) -
Bone Marrow-Mesenchymal Stromal Cell Secretome as Conditioned Medium Relieves Experimental Skeletal Muscle Damage Induced by Ex Vivo Eccentric Contraction
by: Roberta Squecco, et al.
Published: (2021-03-01) -
Proteomic Profiling of the Human Fetal Multipotent Mesenchymal Stromal Cells Secretome
by: Arseniy A. Lobov, et al.
Published: (2020-11-01)